Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids
Bibliographic Data
| ID | 14907375 |
|---|---|
| Authors | Joshua A Barocas (0000-0002-4155-4697, Boston University, corresponding author), Jake R Morgan (0000-0002-1559-3983, Boston University), David A Fiellin (0000-0002-4006-010X), Bruce R Schackman (0000-0002-1132-2932, Cornell University), Golnaz Eftekhari Yazdi (Boston Medical Center), Michael D Stein (0000-0002-2466-5192, Boston University), Kenneth A Freedberg (0000-0001-6471-7930, Harvard University), Benjamin P Linas (0000-0002-9781-9690, Boston University) |
| Year | 2019 |
| Volume | 72 |
| Pages | 160-168 |
| Publication date | 2019-10-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2019.05.010 |
| PMID | 31085063 |
| OpenAlex | W2944344051 |
| Language | EN |
| Citations received | 8 |
| References cited | 57 |
Buprenorphine · Environmental health · Family medicine · Hepatitis C · Intensive care medicine · Opiate Substitution Treatment · Opioid · Opioid use disorder · Population · Referral · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Emergency Medicine · Internal Medicine
Community-involved economic evaluation and development of a cost-effectiveness calculator for two peer-driven substance use interventions
Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia
Health utility among people who regularly use opioids in Australia
The Prevalence and Negative Impacts of Substance Use Disorders among People with HIV in the United States
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment
The use of health utility in cost-utility analysis
Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam
Elimination of hepatitis C virus infection among people who use drugs
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mortality among people who inject drugs
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs
Opiate substitution treatment and HIV transmission in people who inject drugs
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies
HIV-infected individuals who use alcohol and other drugs, and virologic suppression
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID)
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
"Mortality among injection drug users identified as "out of treatment
Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
The Lifetime Medical Cost Savings From Preventing HIV in the United States
| Unique citing works | 8 |
|---|---|
| Citations per year | 1,14 |
| Citation span | 2019 - 2025 (7) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 8 |